According to a new study from the University of Waterloo, synthetic cannabidiol (CBD) may provide some protection against COVID-19.
According to the University of Waterloo, cannabidiol and the anti-viral response to SARS-CoV-2 proteins discovered that the non-psychoactive substance “appears to prime the innate immune system of cells, potentially affording protection against viruses such as SARS-CoV-2.”
According to the experts at the school, CBD enhances the cell’s response to a variety of key proteins produced by the coronavirus genome. The effect had never been discovered before, according to the study.
The researchers studied how proteins from the genome functioned in human kidney cells and healthy control cells, both with and without CBD, according to the university.
Prof. Robin Duncan, the study’s chief scientist, explained, “When cells in the lungs or the digestive tract are infected with a virus, they have the potential to sense and respond even before the immune system knows a virus is present.”
“They accomplish this by triggering innate responses within cells, which serve as the initial line of defence.” However, in the case of COVID-19, this response is inadequate, contributing to high infection rates.”
She claims that when a virus like COVID-19 infects cells, the cells generally activate an internal system that shreds the virus while also killing the cells before they can truly dig in.
“This has the potential to stop an illness, slow its spread in the body, or even cure it.”
She went on to say that therapeutic doses of CBD seemed to improve the cells’ capacity to respond to viral infections in cells that had never been exposed to the coronavirus before.
“This shows CBD at the proper amount could assist cells be in a better state of preparation to respond to a virus, but it doesn’t create a response unless there is a need,” said Maria Fernandes, who led the cell experiments.
Duncan backed up her claim with a research from the United States, which found that epileptic patients who took a high-dose pharmaceutical CBD had a 10-fold decreased likelihood of testing positive for COVID-19.
She reminded out that CBD, unlike THC, does not create a high, making it a safer substance.
CBD may help cells prepare for COVID infection.
Cannabidiol, a nonpsychoactive cannabinoid found in marijuana, appears to boost cells’ innate immune systems, perhaps defending them from infections such as SARS-CoV-2.
Synthetic cannabidiol (CBD) increases cells’ antiviral response to three previously unknown proteins produced by the SARS-CoV-2 genome, according to researchers.
The researchers studied these proteins in human kidney cells, both alone and in combination with CBD, as well as CBD’s effects on healthy control cells.
“When cells in the lungs or the digestive tract are infected with a virus, they have the capacity to feel and respond even before the immune system recognises a virus,” said Robin Duncan, the study’s main investigator and professor of microbiology and immunology.